Mawer Investment Management Ltd. Raises Position in Ryan Specialty Holdings Inc. $RYAN

Mawer Investment Management Ltd. boosted its stake in Ryan Specialty Holdings Inc. (NYSE:RYAN) by 11.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 525,172 shares of the company’s stock after buying an additional 55,716 shares during the period. Mawer Investment Management Ltd.’s holdings in Ryan Specialty were worth $27,115,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Beck Mack & Oliver LLC purchased a new stake in Ryan Specialty in the third quarter worth about $2,818,000. Westview Management dba Westview Investment Advisors bought a new position in shares of Ryan Specialty during the fourth quarter valued at approximately $2,082,000. Geneva Capital Management LLC increased its stake in shares of Ryan Specialty by 11.2% during the third quarter. Geneva Capital Management LLC now owns 535,742 shares of the company’s stock valued at $30,194,000 after purchasing an additional 53,810 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Ryan Specialty by 149.7% during the third quarter. JPMorgan Chase & Co. now owns 421,330 shares of the company’s stock valued at $23,746,000 after purchasing an additional 252,582 shares in the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Ryan Specialty during the fourth quarter valued at approximately $20,776,000. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Ryan Specialty Price Performance

Shares of RYAN opened at $33.09 on Tuesday. The company has a market capitalization of $8.72 billion, a P/E ratio of 42.97, a price-to-earnings-growth ratio of 0.77 and a beta of 0.64. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 2.90. The firm has a 50 day moving average of $33.70 and a 200 day moving average of $43.23. Ryan Specialty Holdings Inc. has a twelve month low of $29.28 and a twelve month high of $72.50.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.04. The company had revenue of $795.23 million during the quarter, compared to the consensus estimate of $781.44 million. Ryan Specialty had a net margin of 8.21% and a return on equity of 41.33%. The firm’s quarterly revenue was up 15.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.39 earnings per share. As a group, equities research analysts anticipate that Ryan Specialty Holdings Inc. will post 2.04 earnings per share for the current fiscal year.

Ryan Specialty announced that its Board of Directors has authorized a stock buyback plan on Tuesday, May 26th that permits the company to buyback $300.00 million in shares. This buyback authorization permits the company to reacquire up to 3.5% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.

Ryan Specialty Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Investors of record on Tuesday, May 12th were given a dividend of $0.13 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $0.52 annualized dividend and a dividend yield of 1.6%. Ryan Specialty’s dividend payout ratio (DPR) is 67.53%.

Wall Street Analysts Forecast Growth

RYAN has been the subject of a number of analyst reports. Keefe, Bruyette & Woods reaffirmed an “outperform” rating on shares of Ryan Specialty in a research note on Tuesday, May 26th. BMO Capital Markets downgraded shares of Ryan Specialty from an “outperform” rating to a “market perform” rating and decreased their target price for the company from $66.00 to $43.00 in a research note on Wednesday, February 25th. UBS Group set a $39.00 target price on shares of Ryan Specialty in a research note on Thursday, May 21st. Wells Fargo & Company downgraded shares of Ryan Specialty from an “overweight” rating to an “equal weight” rating and decreased their target price for the company from $42.00 to $31.00 in a research note on Friday, May 1st. Finally, Zacks Research downgraded shares of Ryan Specialty from a “hold” rating to a “strong sell” rating in a research note on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, Ryan Specialty presently has an average rating of “Hold” and an average price target of $46.76.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.